HSCT-GAVE as a Manifestation of Chronic Graft versus Host Disease: A Case Report and Review of the Existing Literature.
Abstract
Gastric antral vascular ectasia or "watermelon stomach" is a significant cause of
nonvariceal upper GI bleeding and is characterized by red, tortuous ectatic vessels
along longitudinal folds in the gastric antrum. The existing literature links GAVE
to patients with cirrhosis, scleroderma, bone marrow transplantation, and chronic
renal failure among other associations, but its pathophysiology remains ill-defined.
Over 30 cases of hematopoietic stem cell transplant-related GAVE (HSCT-GAVE) have
been reported in the literature to date and there are likely many more that go undiagnosed
or are attributed to another cause of upper gastrointestinal bleeding. Interestingly,
a busulfan-containing conditioning regimen has been the primary factor implicated
in the etiology of HSCT-GAVE because this was common to all cases in the literature
to date. Here, we present the first case of HSCT-GAVE in a patient that was treated
with a non-busulfan-containing conditioning regimen. We propose a link between chronic
GVHD and the development of HSCT-GAVE that is supported by a similar development of
GAVE in patients with systemic sclerosis.
Type
Journal articlePermalink
https://hdl.handle.net/10161/17101Published Version (Please cite this version)
10.1155/2018/2376483Publication Info
Grant, Michael J; & Horwitz, Mitchell E (2018). HSCT-GAVE as a Manifestation of Chronic Graft versus Host Disease: A Case Report and
Review of the Existing Literature. Case reports in transplantation, 2018. 10.1155/2018/2376483. Retrieved from https://hdl.handle.net/10161/17101.This is constructed from limited available data and may be imprecise. To cite this
article, please review & use the official citation provided by the journal.
Collections
More Info
Show full item recordScholars@Duke
Mitchell Eric Horwitz
Professor of Medicine
Allogeneic stem cell transplantation with a focus on the use of umbilical cord blood
grafts; Allogenic stem cell transplantation for Sickle Cell Disease; Prevention of
acute and chronic graft versus host disease; Improving immune recovery following alternative
donor stem cell transplantation using donor graft manipulation.

Articles written by Duke faculty are made available through the campus open access policy. For more information see: Duke Open Access Policy
Rights for Collection: Scholarly Articles
Works are deposited here by their authors, and represent their research and opinions, not that of Duke University. Some materials and descriptions may include offensive content. More info